What the study showed - All-cause mortality at 10 years: 9% with surgery vs 12.4% with GLP1s - Major adverse cardiovascular events: 23.7% with surgery vs 34% with GLP1s - Heart failure: 6.1% with surgery vs 11.9% with GLP1s - Myocardial infarction: 10.7% with surgery vs 15.6% with GLP1s - Stroke: 9.1% with surgery vs 13.7% with GLP1s - Chronic kidney disease: 8.7% with surgery vs 16.3% with GLP1s - Diabetic retinopathy: 17.6% with surgery vs 30.8% with GLP1s - Sustained weight loss: 22% average reduction after surgery vs 7% with GLP1s Looked at this way, surgery seems to dominate across every endpoint
Endocrine 88:8090 Varadhan L, Humphreys T, Hariman C, Walker AB, Varughese GI (2011) GLP-1 agonist treatment: implications for diabetic retinopathy screening
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: A randomized controlled trial
Even though liposomal vitamin C has been shown to be more efficiently absorbed by the bod, this doesnt mean that other vitamin C supplements are ineffective
Is it ok to continue using some brightening cream or gel along with glutathione tablets
Our team will discuss payment options during your consultation
